INVO Bioscience Inc (INVO)
0.9046
+0.03
(+3.97%)
USD |
NASDAQ |
May 24, 10:10
INVO Bioscience Cash and Short Term Investments (Quarterly): 0.4751M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.4751M |
December 31, 2023 | 0.2324M |
September 30, 2023 | 1.056M |
June 30, 2023 | 0.1125M |
March 31, 2023 | 2.188M |
December 31, 2022 | 0.0901M |
September 30, 2022 | 0.2857M |
June 30, 2022 | 1.962M |
March 31, 2022 | 3.840M |
December 31, 2021 | 5.685M |
September 30, 2021 | 4.713M |
June 30, 2021 | 6.643M |
March 31, 2021 | 8.423M |
December 31, 2020 | 10.10M |
September 30, 2020 | 0.9083M |
June 30, 2020 | 1.504M |
March 31, 2020 | 0.35M |
Date | Value |
---|---|
December 31, 2019 | 1.239M |
September 30, 2019 | 2.010M |
June 30, 2019 | 2.663M |
March 31, 2019 | 3.058M |
December 31, 2018 | 0.2122M |
September 30, 2018 | 0.548M |
June 30, 2018 | 0.7203M |
March 31, 2018 | 0.0354M |
December 31, 2017 | 0.0258M |
September 30, 2017 | 0.0353M |
June 30, 2017 | 0.0181M |
March 31, 2017 | 0.0396M |
December 31, 2016 | 0.1524M |
September 30, 2016 | 0.2586M |
June 30, 2016 | 0.3236M |
March 31, 2016 | 0.4233M |
December 31, 2015 | 0.492M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.0901M
Minimum
Dec 2022
10.10M
Maximum
Dec 2020
2.724M
Average
1.733M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Abbott Laboratories | 6.651B |
Perspective Therapeutics Inc | 180.65M |
Xtant Medical Holdings Inc | 4.547M |
Asensus Surgical Inc | 7.989M |
Catheter Precision Inc | 1.491M |